Filip Van Wanzeele

869 total citations
20 papers, 623 citations indexed

About

Filip Van Wanzeele is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Filip Van Wanzeele has authored 20 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Filip Van Wanzeele's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (10 papers). Filip Van Wanzeele is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (10 papers). Filip Van Wanzeele collaborates with scholars based in Belgium, Luxembourg and United States. Filip Van Wanzeele's co-authors include Chris Verhofstede, Jean Plum, Bea Van Der Gucht, Nancy De Cabooter, Dirk Vogelaers, Jos Van Acker, Vic Arendt, Marc De Buyzere, Jolanda Pelgrom and R Hemmer and has published in prestigious journals such as PLoS ONE, Virology and AIDS.

In The Last Decade

Filip Van Wanzeele

20 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Filip Van Wanzeele Belgium	12	408	359	107	67	49	20	623
R Roué France	13	195 0.5×	123 0.3×	141 1.3×	61 0.9×	10 0.2×	37	592
Lars M. Koenig Germany	11	219 0.5×	138 0.4×	95 0.9×	102 1.5×	19 0.4×	12	619
Olivia Chan Canada	6	141 0.3×	233 0.6×	112 1.0×	72 1.1×	10 0.2×	7	599
Emily J. Ciccone United States	14	132 0.3×	150 0.4×	106 1.0×	71 1.1×	19 0.4×	43	626
Peter Mariuz United States	9	246 0.6×	114 0.3×	242 2.3×	140 2.1×	18 0.4×	14	603
Wendy N. Dobson-Belaire Canada	6	157 0.4×	253 0.7×	121 1.1×	69 1.0×	4 0.1×	7	555
Christiane Rollenhagen United States	17	207 0.5×	149 0.4×	134 1.3×	21 0.3×	27 0.6×	28	685
Gema Méndez‐Lagares United States	15	146 0.4×	277 0.8×	162 1.5×	90 1.3×	6 0.1×	22	638
Carline Vanden Abeele Belgium	10	237 0.6×	180 0.5×	116 1.1×	83 1.2×	14 0.3×	19	415

Countries citing papers authored by Filip Van Wanzeele

Since Specialization

Citations

This map shows the geographic impact of Filip Van Wanzeele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Van Wanzeele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Van Wanzeele more than expected).

Fields of papers citing papers by Filip Van Wanzeele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Van Wanzeele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Van Wanzeele. The network helps show where Filip Van Wanzeele may publish in the future.

Co-authorship network of co-authors of Filip Van Wanzeele

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Van Wanzeele. A scholar is included among the top collaborators of Filip Van Wanzeele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Van Wanzeele. Filip Van Wanzeele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scheerder, Marie‐Angélique De, Henrik Zetterberg, Dietmar Fuchs, et al.. (2020). Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption. Journal of Antimicrobial Chemotherapy. 75(5). 1311–1320. 13 indexed citations

Libois, Agnès, Éric Florence, Inge Derdelinckx, et al.. (2018). Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017. Acta Clinica Belgica. 73(4). 275–280. 6 indexed citations

Degroote, Sophie, Dirk Vogelaers, Peter Vermeir, et al.. (2014). Determinants of adherence in a cohort of Belgian HIV patients: a pilot study. Acta Clinica Belgica. 69(2). 111–115. 11 indexed citations

Mortier, Virginie, Kenny Dauwe, Leen Vancoillie, et al.. (2013). Frequency and Predictors of HIV-1 Co-receptor Switch in Treatment Naive Patients. PLoS ONE. 8(11). e80259–e80259. 7 indexed citations

Degroote, Sophie, Dirk Vogelaers, Peter Vermeir, et al.. (2013). Socio‐economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study. Journal of the International AIDS Society. 16(1). 18643–18643. 45 indexed citations

Speeckaert, Reinhart, Robert Colebunders, Johan R. Boelaert, et al.. (2011). Association of haptoglobin phenotypes with the development of Kaposi’s sarcoma in HIV patients. Archives of Dermatological Research. 303(10). 763–769. 11 indexed citations

Verhofstede, Chris, et al.. (2010). Viral load assay sensitivity and low level viremia in HAART treated HIV patients. Journal of Clinical Virology. 47(4). 335–339. 21 indexed citations

Wanzeele, Filip Van, Els Demecheleer, Kenny Dauwe, et al.. (2008). Impact of Δ32-CCR5 heterozygosity on HIV-1 genetic evolution and variability—A study of 4 individuals infected with closely related HIV-1 strains. Virology. 379(2). 213–222. 11 indexed citations

Verhofstede, Chris, Filip Van Wanzeele, Bea Van Der Gucht, et al.. (2007). Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV‐1 viral rebounds of less than 1,000 RNA copies/ml. Journal of Medical Virology. 79(9). 1254–1260. 12 indexed citations

10.

Steyaert, Sophia, Leo Heyndríckx, Lieven Verhoye, et al.. (2007). Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients. Antiviral Research. 75(2). 129–138. 3 indexed citations

11.

Wanzeele, Filip Van, et al.. (2007). Infections and Immunosuppression as Specific Problems in a HIV + Patient Transplanted for End-Stage Alcoholic Cirrhosis. Acta chirurgica Belgica. 107(2). 215–218. 1 indexed citations

12.

Verhofstede, Chris, Els Demecheleer, Nancy De Cabooter, et al.. (2004). Drug-Resistant Variants That Evolve During Nonsuppressive Therapy Persist in HIV-1–Infected Peripheral Blood Mononuclear Cells After Long-Term Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(5). 473–483. 50 indexed citations

13.

Moerman, Mieke, et al.. (2001). Recurrent Focal Epithelial Hyperplasia due to HPV13 in an HIV-Positive Patient. Dermatology. 203(4). 339–341. 29 indexed citations

14.

Vaerenbergh, Kristien Van, Kristel Van Laethem, Eric Van Wijngaerden, et al.. (2000). Baseline HIV Type 1 Genotypic Resistance to a Newly Added Nucleoside Analog Is Predictive of Virologic Failure of the New Therapy. AIDS Research and Human Retroviruses. 16(6). 529–537. 13 indexed citations

15.

Gisolf, Elisabeth H., Suzanne Jurriaans, Jolanda Pelgrom, et al.. (2000). The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. AIDS. 14(4). 405–413. 39 indexed citations

16.

Verhofstede, Chris, Filip Van Wanzeele, Bea Van Der Gucht, Nancy De Cabooter, & Jean Plum. (1999). Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype. AIDS. 13(18). 2541–2546. 129 indexed citations

17.

Colebunders, Robert, Nathan Clumeck, Éric Florence, et al.. (1999). Safe and Effective Use of Combination Antiretroviral Treatment. Acta Clinica Belgica. 54(2). 55–60. 3 indexed citations

18.

Delanghe, Joris, Michel R. Langlois, Johan R. Boelaert, et al.. (1998). Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS. 12(9). 1027–1032. 143 indexed citations

19.

Staszewski, Schlomo, Veronica Miller, Robert Colebunders, et al.. (1996). Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Antiviral Therapy. 1(1). 43–51. 5 indexed citations

20.

Verhofstede, Chris, et al.. (1994). Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection. AIDS. 8(10). 1421–1428. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact